Detalhe da pesquisa
1.
The COVID-19 Pandemic: A Health Crisis Managed or a Panic Response with Disastrous Future Consequences?
Med Princ Pract
; 31(1): 1-10, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662884
2.
Correction: Al-Zamel, N., et al. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019, 20, 3532.
Int J Mol Sci
; 21(9)2020 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32397501
3.
A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.
Int J Mol Sci
; 20(14)2019 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330984
4.
Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.
Med Princ Pract
; 25 Suppl 2: 28-40, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26849149
5.
Involvement of Membrane Blebbing in Immunological Disorders and Cancer.
Med Princ Pract
; 25 Suppl 2: 18-27, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26488882
6.
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.
Carcinogenesis
; 36 Suppl 1: S128-59, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26106135
7.
Breast screening: an obsessive compulsive disorder.
Cancer Causes Control
; 25(10): 1423-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25011404
8.
The effect of lactate dehydrogenase inhibitors on proliferation, motility and invasion of breast cancer cells in vitro highlights a new role for lactate.
Mol Med Rep
; 29(1)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997856
9.
Nerve growth factor enhances cough via a central mechanism of action.
Pharmacol Res
; 74: 68-77, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23742790
10.
α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling.
PLoS One
; 18(7): e0289098, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490473
11.
MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines.
Biochem Biophys Rep
; 31: 101316, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879960
12.
Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
PLoS One
; 17(8): e0272449, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917304
13.
Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility in vitro.
Front Pharmacol
; 12: 747001, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34744727
14.
Psiadin and plectranthone selectively inhibit colorectal carcinoma cells proliferation via modulating cyclins signaling and apoptotic pathways.
PLoS One
; 16(6): e0252820, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34086816
15.
Hypoxic environment may enhance migration/penetration of endocrine resistant MCF7- derived breast cancer cells through monolayers of other non-invasive cancer cells in vitro.
Sci Rep
; 10(1): 1127, 2020 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980706
16.
Aquaporin expression in breast cancer and their involvement in bleb formation, cell motility and invasion in endocrine resistant variant cells.
Int J Oncol
; 56(4): 1014-1024, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319574
17.
Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects.
Pulm Pharmacol Ther
; 22(3): 243-52, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19146972
18.
Molecular genotyping and frequencies of A1, A2, B, O1 and O2 alleles of the ABO blood group system in a Kuwaiti population.
Int J Hematol
; 87(3): 303-9, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18247104
19.
Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells.
PLoS One
; 13(3): e0193779, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590154
20.
Inhibitors of PI3K/ERK1/2/p38 MAPK Show Preferential Activity Against Endocrine-Resistant Breast Cancer Cells.
Oncol Res
; 25(8): 1283-1295, 2017 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28276317